Antiviral effects of ascorbic and dehydroascorbic acids in vitro

  • Authors:
    • Ayami Furuya
    • Misao Uozaki
    • Hisashi Yamasaki
    • Tsutomu Arakawa
    • Mikio Arita
    • A. Hajime Koyama
  • View Affiliations

  • Published online on: Wednesday, October 1, 2008
  • Pages: 541-545
  • DOI: 10.3892/ijmm_00000053

Abstract

In the present study, ascorbic acid weakly inhibited the multiplication of viruses of three different families: herpes simplex virus type 1 (HSV-1), influenza virus type A and poliovirus type 1. Dehydroascorbic acid, an oxidized form of ascorbic acid and hence without reducing ability, showed much stronger antiviral activity than ascorbic acid, indicating that the antiviral activity of ascorbic acid is due to factors other than an antioxidant mechanism. Moreover, addition of 1 mM Fe3+, which oxidizes ascorbic acid to dehydroascorbic acid and also enhances the formation of hydroxyl radicals by ascorbic acid in the culture media, strongly enhanced the antiviral activity of ascorbic acid to a level significantly stronger than that of dehydroascorbic acid. Although both ascorbic acid and dehydroascorbic acid showed some cytotoxicity, the degree of cytotoxicity of the former was 10-fold higher than the latter, suggesting that the observed antiviral activity of ascorbic acid with and without ferric ion is, at least in part, a secondary result of the cytotoxic effect of the reagent, most likely due to the free radicals. However, the possibility that oxidation of ascorbic acid also contributed to the antiviral effects of ascorbic acid exists, in particular in the presence of ferric ion, since dehydroascorbic acid exhibited a very strong antiviral activity. Characterization of the mode of antiviral action of dehydroascorbic acid revealed that the addition of the reagent even at 11 h post infection almost completely inhibited the formation of progeny infectious virus in the infected cells, indicating that the reagent inhibits HSV-1 multiplication probably at the assembly process of progeny virus particles after the completion of viral DNA replication.
Journal Cover

October 2008
Volume 22 Issue 4

Print ISSN: 1107-3756
Online ISSN:1791-244X

2013 Impact Factor: 1.88
Ranked #27/122 Medicine Research and Experimental
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Furuya, A., Uozaki, M., Yamasaki, H., Arakawa, T., Arita, M., & Koyama, A. (2008). Antiviral effects of ascorbic and dehydroascorbic acids in vitro. International Journal of Molecular Medicine, 22(4), 541-545.
MLA
Furuya, Uozaki, Yamasaki, Arakawa, Arita, and A. Koyama. "Antiviral effects of ascorbic and dehydroascorbic acids in vitro." International Journal of Molecular Medicine International Journal of Molecular Medicine 22.4 (2008): 541-545.
Chicago
Furuya, Uozaki, Yamasaki, Arakawa, Arita, and A. Koyama. "Antiviral effects of ascorbic and dehydroascorbic acids in vitro." International Journal of Molecular Medicine International Journal of Molecular Medicine 22 no. 4 (2008): 541-545.